Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 28 (RPL7AP28)

Target
RPL7AP28
Molecular classification
Other (processed pseudogene; not an enzyme, receptor, transporter, transcription factor, etc.)
01

Overview

Ribosomal protein L7a pseudogene 28 (RPL7AP28) is a nonprotein-coding processed pseudogene found on chromosome 6q21 in the human genome[4]. It is derived from the mRNA of the functional ribosomal protein L7a gene (RPL7A), but because it has no exons and does not encode a protein, it is classified as a pseudogene[4][6][8]. Processed pseudogenes such as RPL7AP28 are generally considered genomic "fossils" created by retrotransposition events; they are widely distributed in the genome due to the essential nature and abundance of ribosomal protein genes[12]. While some pseudogenes have regulatory roles, there is no evidence that RPL7AP28 affects human biology or disease[1][4][6][8]. Key points: - This is a nonfunctional, noncoding pseudogene and not a receptor, protein, or therapeutic target. - Only the parent gene (RPL7A) encodes a functional ribosomal protein, important for protein synthesis[3][7]. - If you require information about the ribosomal protein L7a, refer specifically to the RPL7A gene/protein. Summary: RPL7AP28 is a processed pseudogene with no protein product or therapeutic relevance; it serves no recognized biological or disease role and has no interacting drugs or known biomarkers[1][4][6][8]. If you are searching for a valid therapeutic target, information should be redirected to the parent gene/protein, ribosomal protein L7a (RPL7A)[3][7].

Other names
RPL7A_10_519RPL7AP28ribosomal protein L7a pseudogene 28RPL7_12_736

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 28 (RPL7AP28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 28 (RPL7AP28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call